oncology
ConcertAI is expanding its collaboration with Janssen to improve study design and increase diversity in clinical trials.
Rutherford Health Chief Medical Officer Karol Sikora highlights the most pressing needs in cancer treatment today and how he envisages treatment decision-making in the next decade.
The solution uses AI and machine learning to improve adherence.
Patients can digitally request a refill and answer questions about their condition, adherence and side effects.
The new tool helps synthesize information from EHRs, payers, clinical trials and reports.
The data-driven blood glucose monitor system-maker will use the money to push into new areas of disease management, such as cardiology, oncology and women's health.
The service enables patients from the region to make informed decisions about cancer care, with the aim of expanding their treatment options and improving clinical outcomes.
As part of the acquisition Kaiku Health's symptom-tracking tool will be integrated into Elekta's oncology informatics platform.
The new funds will be put towards growing its diagnostic and testing products.
The latest round was led by Atlanta Technology Angels and the Robbins Fund.